COPD drugs is a medicine used to treatment chronic obstructive pulmonary disease, such as bronchodilators, pde-4 inhibitors? steroids, combination therapies, etc.
This report aims to provide a comprehensive presentation of the global market for COPD Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COPD Drugs. This report contains market size and forecasts of COPD Drugs in global, including the following market information:
Global COPD Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global COPD Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
One of the emerging trends propelling the growth prospects for this market is the augmented focus and use of combination therapies to treat COPD. Combination therapies are increasingly becoming the preferred choice of treatment as they have better efficacy than monotherapy drugs.
We surveyed the COPD Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global COPD Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global COPD Drugs Market Segment Percentages, by Type, 2022 (%)
Bronchodilators
PDE-4 Inhibitors
Steroids
Combination Therapies
Others
Global COPD Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global COPD Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global COPD Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global COPD Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies COPD Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies COPD Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
GlaxoSmithKline
Merck
Abbott Laboratories
Boehringer Ingelheim
AstraZeneca
Roche Holding AG
Teva Pharmaceutical Industries
Vectura Group
Mylan NV
Outline of Major Chapters:
Chapter 1: Introduces the definition of COPD Drugs, market overview.
Chapter 2: Global COPD Drugs market size in revenue.
Chapter 3: Detailed analysis of COPD Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of COPD Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 COPD Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global COPD Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global COPD Drugs Overall Market Size
2.1 Global COPD Drugs Market Size: 2022 VS 2029
2.2 Global COPD Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top COPD Drugs Players in Global Market
3.2 Top Global COPD Drugs Companies Ranked by Revenue
3.3 Global COPD Drugs Revenue by Companies
3.4 Top 3 and Top 5 COPD Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies COPD Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 COPD Drugs Players in Global Market
3.6.1 List of Global Tier 1 COPD Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 COPD Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global COPD Drugs Market Size Markets, 2022 & 2029
4.1.2 Bronchodilators
4.1.3 PDE-4 Inhibitors
4.1.4 Steroids
4.1.5 Combination Therapies
4.1.6 Others
4.2 By Type - Global COPD Drugs Revenue & Forecasts
4.2.1 By Type - Global COPD Drugs Revenue, 2018-2023
4.2.2 By Type - Global COPD Drugs Revenue, 2024-2029
4.2.3 By Type - Global COPD Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global COPD Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global COPD Drugs Revenue & Forecasts
5.2.1 By Application - Global COPD Drugs Revenue, 2018-2023
5.2.2 By Application - Global COPD Drugs Revenue, 2024-2029
5.2.3 By Application - Global COPD Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global COPD Drugs Market Size, 2022 & 2029
6.2 By Region - Global COPD Drugs Revenue & Forecasts
6.2.1 By Region - Global COPD Drugs Revenue, 2018-2023
6.2.2 By Region - Global COPD Drugs Revenue, 2024-2029
6.2.3 By Region - Global COPD Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America COPD Drugs Revenue, 2018-2029
6.3.2 US COPD Drugs Market Size, 2018-2029
6.3.3 Canada COPD Drugs Market Size, 2018-2029
6.3.4 Mexico COPD Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe COPD Drugs Revenue, 2018-2029
6.4.2 Germany COPD Drugs Market Size, 2018-2029
6.4.3 France COPD Drugs Market Size, 2018-2029
6.4.4 U.K. COPD Drugs Market Size, 2018-2029
6.4.5 Italy COPD Drugs Market Size, 2018-2029
6.4.6 Russia COPD Drugs Market Size, 2018-2029
6.4.7 Nordic Countries COPD Drugs Market Size, 2018-2029
6.4.8 Benelux COPD Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia COPD Drugs Revenue, 2018-2029
6.5.2 China COPD Drugs Market Size, 2018-2029
6.5.3 Japan COPD Drugs Market Size, 2018-2029
6.5.4 South Korea COPD Drugs Market Size, 2018-2029
6.5.5 Southeast Asia COPD Drugs Market Size, 2018-2029
6.5.6 India COPD Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America COPD Drugs Revenue, 2018-2029
6.6.2 Brazil COPD Drugs Market Size, 2018-2029
6.6.3 Argentina COPD Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa COPD Drugs Revenue, 2018-2029
6.7.2 Turkey COPD Drugs Market Size, 2018-2029
6.7.3 Israel COPD Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia COPD Drugs Market Size, 2018-2029
6.7.5 UAE COPD Drugs Market Size, 2018-2029
7 COPD Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer COPD Drugs Major Product Offerings
7.1.4 Pfizer COPD Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis COPD Drugs Major Product Offerings
7.2.4 Novartis COPD Drugs Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline COPD Drugs Major Product Offerings
7.3.4 GlaxoSmithKline COPD Drugs Revenue in Global Market (2018-2023)
7.3.5 GlaxoSmithKline Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck COPD Drugs Major Product Offerings
7.4.4 Merck COPD Drugs Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Abbott Laboratories
7.5.1 Abbott Laboratories Company Summary
7.5.2 Abbott Laboratories Business Overview
7.5.3 Abbott Laboratories COPD Drugs Major Product Offerings
7.5.4 Abbott Laboratories COPD Drugs Revenue in Global Market (2018-2023)
7.5.5 Abbott Laboratories Key News & Latest Developments
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim COPD Drugs Major Product Offerings
7.6.4 Boehringer Ingelheim COPD Drugs Revenue in Global Market (2018-2023)
7.6.5 Boehringer Ingelheim Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca COPD Drugs Major Product Offerings
7.7.4 AstraZeneca COPD Drugs Revenue in Global Market (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Roche Holding AG
7.8.1 Roche Holding AG Company Summary
7.8.2 Roche Holding AG Business Overview
7.8.3 Roche Holding AG COPD Drugs Major Product Offerings
7.8.4 Roche Holding AG COPD Drugs Revenue in Global Market (2018-2023)
7.8.5 Roche Holding AG Key News & Latest Developments
7.9 Teva Pharmaceutical Industries
7.9.1 Teva Pharmaceutical Industries Company Summary
7.9.2 Teva Pharmaceutical Industries Business Overview
7.9.3 Teva Pharmaceutical Industries COPD Drugs Major Product Offerings
7.9.4 Teva Pharmaceutical Industries COPD Drugs Revenue in Global Market (2018-2023)
7.9.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.10 Vectura Group
7.10.1 Vectura Group Company Summary
7.10.2 Vectura Group Business Overview
7.10.3 Vectura Group COPD Drugs Major Product Offerings
7.10.4 Vectura Group COPD Drugs Revenue in Global Market (2018-2023)
7.10.5 Vectura Group Key News & Latest Developments
7.11 Mylan NV
7.11.1 Mylan NV Company Summary
7.11.2 Mylan NV Business Overview
7.11.3 Mylan NV COPD Drugs Major Product Offerings
7.11.4 Mylan NV COPD Drugs Revenue in Global Market (2018-2023)
7.11.5 Mylan NV Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. COPD Drugs Market Opportunities & Trends in Global Market
Table 2. COPD Drugs Market Drivers in Global Market
Table 3. COPD Drugs Market Restraints in Global Market
Table 4. Key Players of COPD Drugs in Global Market
Table 5. Top COPD Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global COPD Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global COPD Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies COPD Drugs Product Type
Table 9. List of Global Tier 1 COPD Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 COPD Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global COPD Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - COPD Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - COPD Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global COPD Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - COPD Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - COPD Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global COPD Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global COPD Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global COPD Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America COPD Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America COPD Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe COPD Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe COPD Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia COPD Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia COPD Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America COPD Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America COPD Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa COPD Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa COPD Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer COPD Drugs Product Offerings
Table 32. Pfizer COPD Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis COPD Drugs Product Offerings
Table 36. Novartis COPD Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. GlaxoSmithKline Company Summary
Table 39. GlaxoSmithKline COPD Drugs Product Offerings
Table 40. GlaxoSmithKline COPD Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. GlaxoSmithKline Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck COPD Drugs Product Offerings
Table 44. Merck COPD Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. Abbott Laboratories Company Summary
Table 47. Abbott Laboratories COPD Drugs Product Offerings
Table 48. Abbott Laboratories COPD Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Abbott Laboratories Key News & Latest Developments
Table 50. Boehringer Ingelheim Company Summary
Table 51. Boehringer Ingelheim COPD Drugs Product Offerings
Table 52. Boehringer Ingelheim COPD Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Boehringer Ingelheim Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca COPD Drugs Product Offerings
Table 56. AstraZeneca COPD Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Roche Holding AG Company Summary
Table 59. Roche Holding AG COPD Drugs Product Offerings
Table 60. Roche Holding AG COPD Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Roche Holding AG Key News & Latest Developments
Table 62. Teva Pharmaceutical Industries Company Summary
Table 63. Teva Pharmaceutical Industries COPD Drugs Product Offerings
Table 64. Teva Pharmaceutical Industries COPD Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Teva Pharmaceutical Industries Key News & Latest Developments
Table 66. Vectura Group Company Summary
Table 67. Vectura Group COPD Drugs Product Offerings
Table 68. Vectura Group COPD Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Vectura Group Key News & Latest Developments
Table 70. Mylan NV Company Summary
Table 71. Mylan NV COPD Drugs Product Offerings
Table 72. Mylan NV COPD Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Mylan NV Key News & Latest Developments
List of Figures
Figure 1. COPD Drugs Segment by Type in 2022
Figure 2. COPD Drugs Segment by Application in 2022
Figure 3. Global COPD Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global COPD Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global COPD Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by COPD Drugs Revenue in 2022
Figure 8. By Type - Global COPD Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global COPD Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global COPD Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global COPD Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global COPD Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global COPD Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global COPD Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America COPD Drugs Revenue Market Share, 2018-2029
Figure 16. US COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe COPD Drugs Revenue Market Share, 2018-2029
Figure 20. Germany COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia COPD Drugs Revenue Market Share, 2018-2029
Figure 28. China COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America COPD Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa COPD Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE COPD Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GlaxoSmithKline COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Abbott Laboratories COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Boehringer Ingelheim COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AstraZeneca COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Roche Holding AG COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Teva Pharmaceutical Industries COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Vectura Group COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Mylan NV COPD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
